Postpartum Depression: Clinical Screening, Diagnosis, Treatment and Follow-up
DOI:
https://doi.org/10.66069/ojspub.27451019Keywords:
Postpartum depression, Screening, Diagnosis, Psychotherapy, Antidepressants, Zuranolone, Follow-upAbstract
Postpartum depression (PPD) can impair maternal functioning, infant care, and family well-being. Effective management requires symptom screening followed by diagnostic evaluation, safety assessment, treatment, and follow-up. This narrative review summarizes clinical guidelines, systematic reviews, and major trials published through October 2026. The Edinburgh Postnatal Depression Scale and Patient Health Questionnaire-9 support screening and symptom monitoring but do not establish diagnosis. Cognitive behavioral therapy, interpersonal psychotherapy, and antidepressants remain established treatments. Oral zuranolone offers a short-course option for selected patients, subject to safety and infant-care planning. A randomized trial supports supervised telemedicine and task-shared psychotherapy. Coordinated obstetric and mental health follow-up supports continuity of care.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Weijing Wang, Kexin Liu, Yongkang Yang

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /www/bryanhousepub/ojs/plugins/generic/citations/CitationsPlugin.inc.php on line 49